Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Wan, Zhihong ^a   Wu, Yichen ^a   Yi, Jing ^b   You, Shaoli ^a   Liu, Hongling ^a   Sun, Zhiqiang ^a   Zhu, Bing ^a   Zang, Hong ^a   Li, Chen ^a   Liu, Fangfang ^a   Li, Dongze ^a   Mao, Yuanli ^a   Xin, Shaojie ^a  

^a BEIJING 302 HOSPITAL   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CYSTATIN C; BIOLOGICAL MARKER;

ACUTE ON CHRONIC LIVER FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD TURCOTTE PUGH SCORE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS RELATED ACUTE ON CHRONIC LIVER FAILURE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL PREDICTION; SURVIVAL RATE; ACUTE-ON-CHRONIC LIVER FAILURE; BLOOD; CAUSE OF DEATH; COMPLICATION; MIDDLE AGED; REPRODUCIBILITY; YOUNG ADULT;

HEPATITIS B VIRUS;

ACUTE-ON-CHRONIC LIVER FAILURE; ADOLESCENT; ADULT; AGED; BILIRUBIN; BIOMARKERS; CAUSE OF DEATH; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; YOUNG ADULT;

EID: 84961287743     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116968     Document Type: Article

References (30)

1. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, et al. (2009) Acute-on-chronic liver failure; consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 3: 269-282. doi: 10.1007/s12072-008-9106-x PMID: 19669378
2. Liver Failure and Artificial Liver Group. Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology (2006) Diagnostic and treatment guidelines for liver failure (2012 version). Zhonghua Gan Zang Bing Za Zhi 14: 643-646. PMID: 16995974
3. Ke WM, Ye YN, Huang S (2003) Discriminate function for prognostic indexes and probability of death in chronic severe hepatitis B. J Gastroenterol 38: 861-864. PMID: 14564632
4. You SL, Rong YH, Zhu B, Zhang AM, Zang H, et al. (2013) Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey. Hepatol Int 7: 714-720.
5. Cárdenas A, Ginès P (2011) Acute-on-chronic liver failure: the kidneys. Curr Opin Crit Care 17:184-189. doi: 10.1097/MCC.0b013e328344b3da PMID: 21311322
6. Jalan R, Gines P, Olson JC, Mookerjee RP, More R, et al. (2012) Acute-on-chronic liver failure. J Hepatol 57: 1336-1348.
7. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, et al. (2013) Acute-on-Chronic Liver Failure is a Distinct Syndrome that Develops in Patients with Acute Decompensation of Cirrhosis. Gastroenterology 144: 1426-1437. doi: 10.1053/j.gastro.2013.02.042 PMID: 23474284
8. Kamath PS, Kim WR (2007) The model for end-stage liver disease (MELD). Hepatology 45: 797-805. PMID: 17326206
9. Seto WK, Lai CL, Yuen MF (2012) Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol 27: 662-669. doi: 10.1111/j.1440-1746.2011.06971.x PMID: 22098452
10. Yu JW, Wang GQ, Li SC (2006) Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol 21: 1519-1524. PMID: 16928211
11. Francoz C, Glotz D, Moreau R, Durand F (2010) The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 52: 605-613. doi: 10.1016/j.jhep.2009.11.025 PMID: 20185192
12. Bellomo R, Kellum JA, Ronco C (2004) Defining acute renal failure: physiological principles. Intensive Care Med 30: 33-37. PMID: 14618231
13. Cholongitas E, Shusang V, Marelli L, Nair D, Thomas M, et al. (2007) Review article: renal function assessment in cirrhosis-difficulties and alternative measurements. Aliment Pharmacol Ther 26: 969-978. PMID: 17877504
14. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, et al. (1995) Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine for glomerular filtration rate. Kidney Int 47: 312-318. PMID: 7731163
15. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, et al. (2013) Cystatin C versus Creatinine in Determining Risk Based on Kidney Function. N Engl J Med 369: 932-943. doi: 10.1056/NEJMoa1214234 PMID: 24004120
16. Gerbes AL, Gulberg V, Bilzer M, Vogeser M (2002) Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 50: 106-110. PMID: 11772976
17. Seo YS, Jung ES, An H, Kim JH, Jung YK, Kim JH, et al. (2009) Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int 29: 1521-1527. doi: 10.1111/j.1478-3231.2009.02105.x PMID: 19725889
18. Sharawey MA, Shawky EM, Ali LH, Ali Mohammed A, Hassan HA, et al. (2011) Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis. Hepatol Int 5: 927-933.
19. Wan ZH, Wang JJ, You SL, Liu HL, Zhu B, et al. (2013) Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure. World J Gastroenterol 19: 9432-9438. doi: 10.3748/wjg.v19.i48.9432 PMID: 24409073
20. Chinese Society of Infectious Diseases and Parasitology. Chinese Society of Hepatology (2000) Management scheme of diagnostic and therapeutic criteria of viral hepatitis. Zhonghua Gan Zang Bing Za Zhi 8: 324-329.
21. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the esophagus for bleeding oesophageal varices. Br J Surg 60: 646-649. PMID: 4541913
22. Garg H, Kumar A, Garg V, Sharma P, Sharma BC, et al. (2012) Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis 44: 166-171. doi: 10.1016/j.dld.2011.08.029 PMID: 21978580
23. Karvellas CJ, Pink F, McPhail M, Austin M, Auzinger G, et al. (2010) Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med 38: 121-126. doi: 10.1097/CCM.0b013e3181b42a1c PMID: 19770744
24. Katoonizadeh A, Laleman W, Verslype C, Wilmer A, Maleux G, et al. (2010) Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 59: 1561-1569. doi: 10.1136/gut.2009.189639 PMID: 20675694
25. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, et al. (2005) Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 42: 195-201. PMID: 15664244
26. Francoz C, Durand F (2012) A new look at renal dysfunction in the cirrhotic patient. Crit Care 16: 118. doi: 10.1186/cc11207 PMID: 22385933
27. Souza VD, Hadj-Aissa A, Dolomanova O, Rabilloud M, Rognant N, et al. (2013) Creatinine-versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis. Hepatology. Oct 9. doi: 10.1002/hep.26886 PMID: 24382638
28. Xia Q, Dai X, Zhang Y, Guo Y, Xu X, et al. (2013) A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients. PLoS One 8: e64379. doi: 10.1371/journal.pone.0064379 PMID: 23755119
29. Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, et al. (2009) Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat 16: 464-470. doi: 10.1111/j.1365-2893.2008.01046.x PMID: 19413694
30. Zheng MH, Shi KQ, Fan YC, Li H, Ye C, et al. (2011) A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol 9: 351-356. doi: 10.1016/j.cgh.2010.12.027 PMID: 21195790